Twelve 13-benzyl-15,16-bisnorlabdanes in which the C-13 and C-14 substituents are varied have been prepared from the naturally occurring labdane diterpene (+)-manool. These synthesised compounds were evaluated for antimalarial activity, in vitro as hemozoin formation inhibitors and in vivo against Plasmodium berghei. These derivatives were also assayed for antileishmanial activity against Leishmania mexicana.
World Health Organization, World malaria report 2012, WHO Press, Switzerland, Geneva, 2012. pp. 88.
2.
World Health Organization, Research priorities for Chagas disease, human African Trypanosomiasis and Leishmaniasis (technical report series, No. 975), WHO Press, Switzerland, Geneva, 2012. pp. 100.
3.
World Health Organization, Global report on antimalarial drug efficacy and drug resistance: 2000–2010, WHO Press, Switzerland, Geneva, 2010. pp. 115.
4.
FarooqU., and MahajanR.J., Vect. Borne. Dis., 2004, 41, 45.
PetersW., and RobinsonB.L., Handbook of animal models of infection, eds ZackO., and SandeM., Academic Press, San Diego, CA, 1999. Malaria, pp. 757–773.
